Leadership Team

The Leadership Team at GID is responsible for guiding the strategic direction and operational execution of the company as it prepares for pivotal Phase III trials of its cellular therapy for knee osteoarthritis. Composed of founders and senior vice presidents, this team focuses on overseeing business development, financial management, and operational efficiency to ensure successful trial outcomes and market readiness.